Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2025-12-27 @ 11:50 PM
Study NCT ID:
NCT01443494
Status:
COMPLETED
Last Update Posted:
2017-07-06
First Post:
2011-09-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High MAP in Septic Shock With Hypertension
Sponsor:
Southeast University, China
Organization:
Study Overview
Official Title:
High Mean Arterial Pressure Target Improves Microcirculation in Septic Shock Patients With Previous Hypertension
Status:
COMPLETED
Status Verified Date:
2017-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We hypothesized that the increase in MAP from 65 mmHg to patients' usual level improved sublingual microcirculation.
Detailed Description:
The effect of mean arterial pressure (MAP) titration to higher level on microcirculation in septic shock patients with previous hypertension remains unknown. Our goal was to assess the effect of MAP titration to patients' usual level on microcirculation in septic shock patients with previous hypertension. We hypothesized that the increase in MAP from 65 mmHg to patients' usual level improved sublingual microcirculation.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: